| Serial Number | 98851818 |
| Word Mark | AP3 |
| Filing Date | Wednesday, November 13, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, June 9, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Pseudo Mark | AP THREE |
| Goods and Services | Medical services; medical testing for diagnosis or treatment purposes; medical diagnostic testing, monitoring, and reporting services; providing medical information, consultancy and advisory services; individual medical counseling services provided to patients; providing a website featuring information in the field of precision medicine; providing medical information to medical professionals in the form of reports in the field of precision medicine |
| Goods and Services | scientific research; medical research; proteomics and biomarker discovery services; scientific research and development in the fields of pharmaceuticals, therapeutics, and drug formulation and delivery; scientific research and development in the fields of proteomics and biomarker discovery; consultancy services in the field of pharmaceutical research and development services; consultancy services in the fields of proteomics and biomarker discovery; pharmaceutical research services related to prediction of drug treatment efficacy; medical research services related to prediction of drug treatment efficacy; conducting scientific studies in the fields of proteomics, biomarker discovery, rational drug design in drug discovery, patient responder identification and indication finding, precision medicine clinical trials based on responder identification; proteomics, biomarker discovery, rational drug design in drug discovery, patient responder identification and indication finding, precision medicine clinical trials based on responder identification services; scientific and technological research and consultation services, namely, in the medical, pharmaceutical, and scientific research fields of drug-tailored, efficacy-predictive biomarkers, pharmacodynamic biomarkers, drug repurposing, patient responder identification, indication finding, and rational drug design; drug discovery services in the medical, pharmaceutical, and scientific research fields of drug-tailored, efficacy-predictive biomarkers, patient responder identification, pharmacodynamic biomarkers, drug repurposing, and rational drug design through optimal pathway effects in intact cells; consultancy in the field of pharmaceutical research and development services in the medical, pharmaceutical, and scientific research fields of drug-tailored, efficacy-predictive biomarkers, patient responder identification, pharmacodynamic biomarkers, drug repurposing, indication finding, and rational drug design through pathway-based SAR |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 13, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 13, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Acrivon Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Watertown, MA 02472 |
| Event Date | Event Description |
| Wednesday, November 13, 2024 | NEW APPLICATION ENTERED |
| Tuesday, May 6, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 9, 2025 | ASSIGNED TO EXAMINER |
| Friday, May 9, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, May 9, 2025 | NON-FINAL ACTION E-MAILED |
| Friday, May 9, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sunday, June 8, 2025 | LETTER OF PROTEST EVIDENCE FORWARDED |
| Monday, June 9, 2025 | LETTER OF PROTEST EVIDENCE REVIEWED - ACTION TAKEN |
| Monday, June 9, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, June 9, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, June 9, 2025 | NON-FINAL ACTION E-MAILED |